ClinVar Miner

Variants studied for familial prostate carcinoma

Included ClinVar conditions (8):
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:
ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign association total
30 17 1 0 0 8 56

Gene and significance breakdown #

Total genes and gene combinations: 17
Download table as spreadsheet
Gene or gene combination pathogenic likely pathogenic uncertain significance association total
BRCA2 18 10 0 0 28
CHEK2 4 1 0 0 5
PTEN 1 3 0 0 4
ATM, C11orf65 3 0 0 0 3
AR, LOC109504725 1 0 1 0 2
ATM 0 2 0 0 2
CASC19 0 0 0 2 2
​intergenic 0 0 0 1 1
BRCA1 1 0 0 0 1
CASC21 0 0 0 1 1
CASC21, CASC8 0 0 0 1 1
CASC8 0 0 0 1 1
CDH1 1 0 0 0 1
HOXB13 1 0 0 0 1
LOC105375751 0 0 0 1 1
MSH6 0 1 0 0 1
PRNCR1 0 0 0 1 1

Submitter and significance breakdown #

Total submitters: 4
Download table as spreadsheet
Submitter pathogenic likely pathogenic uncertain significance association total
Juno Genomics, Hangzhou Juno Genomics, Inc 23 14 1 0 38
Women's Health and Genetics/Laboratory Corporation of America, LabCorp 6 3 0 0 9
University of Washington Center for Mendelian Genomics, University of Washington 0 0 0 8 8
Institute of Human Genetics, Clinical Exome/Genome Diagnostics Group, University Hospital Bonn 1 0 0 0 1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.